Skip to content

Clinical trials

Observational Rare Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rare Diseases Phase: Observational Country / region: Canada Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20171
20181
20191
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status3
Completed2
Recruiting2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Friedreich's Ataxia Research Alliance2
National Center for Research Resources (NCRR)2
NightstaRx Ltd, a Biogen Company1
Prof. Valérie Mc Lin1
REGENXBIO Inc.1
Ultragenyx Pharmaceutical Inc1
University Health Network, Toronto1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rare Diseases9
Friedreich Ataxia2
Genetic Diseases, Inborn2
Neurologic Manifestations2
Ataxia1
Atherosclerosis1
Cardiovascular Diseases1
Congenital Portosystemic Shunt1
Head Injuries, Closed1
Hematologic Diseases1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.